Las Vegas, NV -- (SBWIRE) -- 11/01/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Plug Power Inc (NASDAQ:PLUG), Gastar Exploration Limited (USA) (NYSEMKT: GST), Navidea Biopharmaceuticals Inc (NYSEMKT: NAVB), Rexahn Pharmaceuticals, Inc. (NYSEMKT: RNN)
Plug Power Inc (NASDAQ:PLUG) managed to keep its fall at -4.45% on below -normal volume of 1.19M shares. The stock settled at $0.580 after floating in a range of $0.58 to $0.62. Its latest price has reached market capitalization of $59.10 million. Its 52-week range has been $0.12 to $0.81. Plug Power Inc. (Plug Power), is a provider of alternative energy technology focused on the design, development, commercialization and manufacture of fuel cell systems for the industrial off-road (forklift or material handling) market. The Company is focused on proton exchange membrane( PEM), fuel cell and fuel processing technologies and fuel cell/battery hybrid technologies, from which multiple products are available.
Has PLUG Found The Bottom and Ready To Move Up? Find Out Here
Gastar Exploration Limited (USA) (NYSEMKT: GST) traded up on a volume of 1.18 million, higher than its standard daily volume. Shares have gained 5.37% to $4.32. Over the last twelve months, the stock has gained 278.95% and faced a worst price of $0.70. Gastar Exploration Ltd (Gastar) is an independent energy company engaged in the exploration, development and production of natural gas and oil in the United States.
For How Long GST’s Gloss will Attract Investors? Find out via this report
Navidea Biopharmaceuticals Inc (NYSEMKT: NAVB) settled 1.01% higher at $2 on above-normal volume of 1.16M shares during the last trading day. The stock has its 12-month high at $3.59 and 52-week low price was $1.95. It traded in a range of $195. to $2.07 during the last trading day. Navidea Biopharmaceuticals, Inc. (Navidea), formerly Neoprobe Corporation, is a biopharmaceutical company focused on the development and commercialization of precision diagnostic agents.
Why Should Investors Buy NAVB After the Recent Fall? Just Go Here and Find Out
In the last trading session, Rexahn Pharmaceuticals, Inc. (NYSEMKT: RNN) was down on low volume, trading at a volume of 1.15M shares versus its average daily volume of 1.65 million shares. At $00413, the stock has attained market capitalization of $49.32 million.
Why Should Investors Buy RNN After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)